NCT05520593 Preoperative Oral Hydration in the Ambulatory Arthroplasty Population
| NCT ID | NCT05520593 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital for Special Surgery, New York |
| Condition | Same-day Discharge |
| Study Type | INTERVENTIONAL |
| Enrollment | 312 participants |
| Start Date | 2022-11-07 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 312 participants in total. It began in 2022-11-07 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate if the consumption of a complex carbohydrate drink preoperatively, decreases the length of stay and causes for failure to launch in patients undergoing ambulatory total joint arthroplasty.
Eligibility Criteria
Inclusion Criteria: * Candidates for ambulatory total knee arthroplasty * Candidates for ambulatory total hip arthroplasty * Candidates for ambulatory revision knee arthroplasty (liner exchange only) * Candidates for ambulatory revision hip arthroplasty (liner exchange only) * Case scheduled before noon (12 pm) * Patient agrees to same-day discharge and has a responsible adult to spend the night on the day of discharge Exclusion Criteria: * BMI less than 18.5 or greater than 37.0 * Patients with diabetes, chronic kidney disease, clotting disorders, or neurological conditions preventing control of the affected limb. * Pregnant women * Patients scheduled as ambulatory due to insurance mandates * Patients with a history of active ischemia, significant valvular disease, significant arrhythmias, obstructive sleep apnea as per Hospital for Special Surgery guidelines, chronic opioid dependence (chronic daily opioid use for six or more months), and glomerular filtration rate \< 60ml/min.
Contact & Investigator
Jose A Rodriguez, MD
PRINCIPAL INVESTIGATOR
Hospital for Special Surgery, New York
Frequently Asked Questions
Who can join the NCT05520593 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Same-day Discharge. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05520593 currently recruiting?
Yes, NCT05520593 is actively recruiting participants. Contact the research team at rodriguezjose@hss.edu for enrollment information.
Where is the NCT05520593 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05520593 clinical trial?
NCT05520593 is sponsored by Hospital for Special Surgery, New York. The principal investigator is Jose A Rodriguez, MD at Hospital for Special Surgery, New York. The trial plans to enroll 312 participants.